NCT03109158 2019-04-29NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckNanoCarrier Co., Ltd.Phase 1/2 Completed1 enrolled